{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:06:45Z","timestamp":1772921205639,"version":"3.50.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.2169\/internalmedicine.5686-25","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T22:07:27Z","timestamp":1754518047000},"page":"754-759","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Inflammatory Myositis False-positive for Anti-aminoacyl-tRNA synthetase Antibody Successfully Ameliorated by Immunosuppressive Therapy"],"prefix":"10.2169","volume":"65","author":[{"given":"Masahiro","family":"Akiyama","sequence":"first","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Arinuma","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"},{"name":"Department of Rheumatology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akisato","family":"Nishigaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rufuto","family":"Ando","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoshin","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Sugitani","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"},{"name":"Department of Rheumatology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Ito","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"},{"name":"Department of Rheumatology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"},{"name":"Department of Rheumatology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. De Vooght J, Vulsteke JB, De Haes P, Bossuyt X, Lories R, De Langhe E. Anti-TIF1-\u03b3 autoantibodies: warning lights of a tumour autoantigen. Rheumatology (Oxford) 59: 469-477, 2022.","DOI":"10.1093\/rheumatology\/kez572"},{"key":"2","unstructured":"2. Legault D, McDermott J, Crous-Tsanaclis AM, Boire G. Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome. J Rheumatol 35: 169-171, 2008."},{"key":"3","unstructured":"3. Andr\u00e1s C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35: 438-444, 2008."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Sen\u00e9cal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84: 231-249, 2005.","DOI":"10.1097\/01.md.0000173991.74008.b0"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357: 96-100, 2001.","DOI":"10.1016\/S0140-6736(00)03540-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Andr\u00e1s C, Bodoki L, Nagy-Vincze M, Griger Z, Csiki E, Dank\u00f3 K. Retrospective analysis of cancer-associated myositis patients over the past 3 decades in a Hungarian myositis cohort. Pathol Oncol Res 26: 1749-1755, 2020.","DOI":"10.1007\/s12253-019-00756-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Selva-O'Callaghan A, Trallero-Aragu\u00e1s E, Ros J, et al. Management of cancer-associated myositis. Curr Treatm Opt Rheumatol 8: 91-104, 2022.","DOI":"10.1007\/s40674-022-00197-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lega JC, Fabien N, Reynaud Q, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 13: 883-891, 2014.","DOI":"10.1016\/j.autrev.2014.03.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Izuka S, Komai T, Shoda H, Fujio K. Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy. Rheumatol Int 43: 335-343, 2023.","DOI":"10.1007\/s00296-022-05214-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yang H, Peng Q, Yin L, et al. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19: 259, 2017.","DOI":"10.1186\/s13075-017-1469-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Park SG, Schimmel P, Kim S. Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A 105: 11043-11049, 2008.","DOI":"10.1073\/pnas.0802862105"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sasai T, Ishikawa Y, Nakashima R, et al. Anti-aminoacyl tRNA synthetase antibodies showing the discrepancy between enzyme-linked immunosorbent assay and RNA-immunoprecipitation. Immunol Med 47: 166-175, 2024.","DOI":"10.1080\/25785826.2024.2328918"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shinoda K, Okumura M, Yamaguchi S, et al. A comparison of line blots, enzyme-linked immunosorbent, and RNA-immunoprecipitation assays of antisynthetase antibodies in serum samples from 44 patients. Intern Med 61: 313-322, 2022.","DOI":"10.2169\/internalmedicine.7824-21"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ghirardello A, Rampudda M, Ekholm L, et al. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49: 2370-2374, 2010.","DOI":"10.1093\/rheumatology\/keq281"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Watkins J, Farzaneh-Far R, Tahir H, Wykes F, Studdy PR, Beynon HL. Jo-1 syndrome with associated poorly differentiated adenocarcinoma. Rheumatology (Oxford) 43: 389-390, 2004.","DOI":"10.1093\/rheumatology\/keg473"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. van der Bijl AE, Meinders AE, van Duinen SG, Tamsma JT. A nasal squamous cell carcinoma complicated by a paraneoplastic syndrome consisting of a myositis and anti-Jo-1 autoantibodies. Eur J Intern Med 16: 369-371, 2005.","DOI":"10.1016\/j.ejim.2004.11.020"},{"key":"17","unstructured":"17. Nakanishi S, Hatayama T. Adenocarcinoma of the prostate associated with anti Jo-1 antibody positive polymyositis. Hinyokika Kiyo (Acta Urol Jpn) 52: 289-291, 2006 (in Japanese)."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Mescam-Mancini L, Allenbach Y, Hervier B, et al. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. Brain 138: 2485-2492, 2015.","DOI":"10.1093\/brain\/awv192"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang Q, Li Y, Ji S, Feng F, Bu B. Immunopathological characterization of muscle biopsy samples from immune-mediated necrotizing myopathy patients. Med Sci Monit 24: 2189-2196, 2018.","DOI":"10.12659\/MSM.907380"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/5\/65_5686-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:45:45Z","timestamp":1772855145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/5\/65_5686-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5686-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]},"article-number":"5686-25"}}